Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel
ClinicalTrials.gov study NCT05199961. IPD Sharing: NO. Countries: 1. Publications: 14.
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide
ClinicalTrials.gov study NCT03804372. IPD Sharing: NO. Countries: 1. Publications: 1.
Non-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT04237168. IPD Sharing: NO. Countries: 1. Publications: 5.
Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas
ClinicalTrials.gov study NCT03985696. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy
ClinicalTrials.gov study NCT04316624. IPD Sharing: NO. Countries: 1. Publications: 1.
A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphom
ClinicalTrials.gov study NCT02220842. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT
ClinicalTrials.gov study NCT04516551. IPD Sharing: NO. Countries: 1. Publications: 1.
Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00336843. IPD Sharing: NO. Countries: 1. Publications: 1.
Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03151876. IPD Sharing: YES. Countries: 1. Publications: 1.
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT05303792. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Identification of B Regulatory Cells by Flow Cytometry
ClinicalTrials.gov study NCT06876506. IPD Sharing: NO. Countries: 1. Publications: 3.
Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05805943. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Mature B-cell Lymphoma/Leukaemia
ClinicalTrials.gov study NCT00162656. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients
ClinicalTrials.gov study NCT01357733. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
ClinicalTrials.gov study NCT04161248. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT05645718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
ClinicalTrials.gov study NCT03185494. IPD Sharing: YES. Countries: 1. Publications: 1.
R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT00135499. IPD Sharing: Not stated. Countries: 3. Publications: 4.
Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00971763. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With
ClinicalTrials.gov study NCT01290549. IPD Sharing: Not stated. Countries: 4. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.